Hepatoprotectant ursodeoxycholyl lysophosphatidylethanolamide increasing phosphatidylcholine levels as a potential therapy of acute liver injury

Frontiers in Physiology

Volumn 3 FEB, Issue , 2012, Pages

  Chamulitrat, Walee ^a   Xu, Wujuan Zhang ^a,b   Pathil, Anita ^a   Setchell, Kenneth ^b   Stremmel, Wolfgang ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Acute liver injury; Bile acid phospholipid conjugate; Cytoprotection; Drug poisoning; Pc homeostasis

Indexed keywords

EID: 84866271987     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00024     Document Type: Article

References (42)

1. Aleynik, S. I., Leo, M.A., Ma, X., Aleynik, M. K., and Lieber, C. S. (1997). Poly- enylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis. J. Hepatol. 27, 554-561.
2. Anthérieu, S., Rogue, A., Fromenty, B., Guillouzo, A., and Robin, M. A. (2011). Induction of vesicu- lar steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells. Hepatology 53, 1895-1905.
3. Camacho, J., and Rubalcava, B. (1984). Lipid composition of liver plasma membranes from rats intoxicated with carbon tetrachloride. Biochim. Biophys. Acta 776, 97-104.
4. Chamulitrat, W., Burhenne, J., Rehlen, T., Pathil, A., and Stremmel, W. (2009). Bile salt-phospholipid con- jugate ursodeoxycholyl lysophos- phatidylethanolamine as a hepato- protective agent. Hepatology 50, 143-154.
5. Chatman, L. A., Morton, D., Johnson, T. O., and Anway, S. D. (2009). A strat- egy for risk management of drug- induced phospholipidosis. Toxicol. Pathol. 37, 997-1005.
6. Collins, J. M., Neville, M. J., Hoppa, M. B., and Frayn, K. N. (2010). De novo lipogenesis and stearoyl-CoA desat- urase are coordinately regulated in the human adipocyte and pro- tect against palmitate-induced cell injury. J. Biol. Chem. 28, 6044-6052.
7. Cui, Z., and Houweling, M. (2002). Phosphatidylcholine and cell death. Biochim. Biophys. Acta 1585, 87-96.
8. DeLong, C. J., Shen, Y. J., Thomas, M. J., and Cui, Z. (1999). Molecular distinction of phosphatidyl- choline synthesis between the CDP-choline pathway and phos- phatidylethanolamine methylation pathway. J. Biol. Chem. 274, 29683-29688.
9. Esko, J. D., Nishijima, M., and Raetz, C. R. (1982). Animal cells dependent on exogenous phosphatidylcholine for membrane biogenesis. Proc. Natl. Acad. Sci. U.S.A. 79, 1698-1702.
10. Gebhart, A. M., and Brabec, M. J. (1985). Carbon tetrachloride depresses hepatic phospholipid syn- thesis in rats. Toxicol. Lett. 24, 71-78.
11. Green, C. D., and Olsen, L. K. (2011). Modulation of lipogenesis in hepa- tocytes by SCD-1 and Elovol6. Am. J. Physiol. Endocrinol. Metab. 300, E640-E649.
12. Green, T. J., Sivilotti, M. L., Lang- mann, C., Yarema, M., Juurlink, D., Burns, M. J., and Johnson, D. W. (2010). When do the amino- transferases rise after acute aceta- minophen overdose? Clin. Toxicol. (Phila.) 48, 787-792.
13. Hwang, J., Chang, Y. H., Park, J. H., Kim, S. Y., Chung, H., Shim, E., and Hwang, H. J. (2011). Dietary saturated and monounsaturated fats protect against acute acetaminophen hepatotoxicity by altering fatty acid composition of liver microsomal membrane in rats. Lipids Health Dis. 10, 184.
14. Jackowski, S. (1994). Coordination of membrane phospholipid synthesis with the cell cycle. J. Biol. Chem. 269, 3858-3867.
15. Jaeschke, H., Werner, C., and Wendel, A. (1987). Disposition and hepatopro-tectionbyphosphatidylcholinelipo-somes in mouse liver. Chem. Biol. Interact. 64, 127-137.
16. James, J. L., Moody, D. E., Chan, C. H., and Smuckler, E. A. (1982). The phospholipids of the hepatic endoplasmic reticulum. Structural change in liver injury. Biochem. J. 206, 203-210.
17. Kharbanda, K. K., Mailliard, M. E., Baldwin, C. R., Beckenhauer, H. C., Sorrell, M. F., and Tuma, D. J. (2007). Betaine attenuates alco-holic steatosis by restoring phos-phatidylcholine generation via the phosphatidylethanolamine methyl-transferase pathway. J. Hepatol. 46, 314-321.
18. Lee, J. M., Lee, Y. K., Mamrosh, J. L., Busby, S. A., Griffin, P. R., Pathak, M. C., Ortlund, E. A., and Moore, D. D. (2011). A nuclear- receptor-dependent phosphatidyl- choline pathway with antidiabetic effects. Nature 474, 506-510.
19. Lee, S. S., Chan, W. Y., Lo, C. K., Wan, D. C., Tsang, D. S., and Cheung, W. T. (2004). Requirement of PPARalpha in maintaining phospholipid and triacylglycerol homeostasis during energy deprivation. J. Lipid Res. 45, 2025-2037.
20. Li, Z., Agellon, L. B., Allen, T. M., Umeda, M., Jewell, L., Mason, A., and Vance, D. E. (2006). The ratio of phosphatidylcholine to phosphatidylethanolamine influ- ences membrane integrity and steatohepatitis. Cell Metab. 3, 321-331.
21. Li, Z., Agellon, L. B., and Vance, D. E. (2005). Phosphatidylcholine home- ostasis and liver failure. J. Biol. Chem. 280, 37798-37802.
22. Lieber, C. S., Weiss, D. G., Groszmann, R., and Paronetto, F. II. (2003). Veterans affairs cooperative study of polyenyl-phosphatidylcholine in alcoholic liver disease. Alcohol. Clin. Exp. Res. 27, 1765-1772.
23. Lin, C. H., Lin, J., and Strickland, K. P. (1991). Bovine brain microsomal CDP-diacylglycerol synthetase: solu- bilization and properties. Biochem. Int. 25, 299-306.
24. Miyazaki, M., Bai, L., and Namba, M. (1991). Extending effects of phospholipids, cholesterol, and ethanolamines on survival of adult rat hepatocytes in serum-free pri- mary culture. Res. Exp. Med. (Berl.) 191, 77-83.
25. Miyazawa, T., Suzuki, T., Fujimoto, K., and Kaneda, T. (1990). Phospholipid hydroperoxide accumulation in liver of rats intoxicated with carbon tetra- chloride and its inhibition by dietary alpha-tocopherol. J. Biochem. 107, 689-693.
26. Noga, A. A., and Vance, D. E. (2003). Insights into the requirement of phosphatidylcholine synthesis for liver function in mice. J. Lipid Res. 44, 1998-2005.
27. Okiyama, W., Tanaka, N., Nakajima, T., Tanaka, E., Kiyosawa, K., Gonzalez, F. J., and Aoyama, T. (2009). Polyene- phosphatidylcholine prevents alco- holic liver disease in PPARalpha- null mice through attenuation of increases in oxidative stress. J. Hepa- tol. 50, 1236-1246.
28. Pan, H. J., Lin, Y., Chen, Y. E., Vance, D. E., and Leiter, E. H. (2006). Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysreg- ulated phosphatidylcholine metabo- lism. Vascul. Pharmacol. 45, 65-71.
29. Pathil, A., Warth, A., Chamulitrat, W., and Stremmel, W. (2011a). The syn- thetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamine suppresses TNFα-induced liver injury. J. Hepatol. 54, 674-684.
30. Pathil, A., Mueller, J., Warth, A., Chamulitrat, W., and Stremmel, W. (2011b). Ursodeoxycholyl lysophos- phatidylethanolamine improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease. Hepatology doi:10.1002/hep.25531. [Epub ahead of print].
31. Saini-Chohan, H. K., Holmes, M. G., Chicco, A. J., Taylor, W. A., Moore, R. L., McCune, S. A., Hickson- Bick, D. L., Hatch, G. M., and Sparagna, G. C. (2009). Cardi- olipin biosynthesis and remodeling enzymes are altered during develop- ment of heart failure. J. Lipid Res. 50, 1600-1608.
32. Sgoutas, D. S. (1967). Phospho- lipid changes during hepatic injury caused by carbon tetrachloride. Metab. Clin. Exp. 16, 382-391.
33. Shimizu, Y. (1969). Effect of carbon tetrachloride administration on the synthesis of triglycerides and phos- pholipids in rat liver. J. Lipid Res. 10, 479-486.
34. Simko, V., and Michael, S. (1994). Effect of ursodeoxycholic acid on in vivo and in vitro toxic liver injury in rats. Aliment. Pharmacol. Ther. 8, 315-322.
35. Slitt, A. L., Naylor, L., Hoivik, J., Man- autou, J. E., Macrides, T., and Cohen, S. D. (2004). The shark bile salt 5 beta-scymnol abates acetaminophen toxicity, but not covalent binding. Toxicology 203, 109-121.
36. Speck, R. F., and Lauterburg, B. H. (1991). Fish oil protects mice against acetaminophen hepato- toxicity in vivo. Hepatology 13, 557-561.
37. Sugano, M., Cho, S., Imaizumi, K., and Wada, M. (1970). Hepatotoxicity and lipid metabolism. 3. Changes in phosphatidylcholine and phosphatidylethanolamine dur- ing hepatic injury caused by carbon tetrachloride. Biochem. Pharmacol. 19, 2325-2333.
38. Trudell, J. R., Bösterling, B., and Trevor, A. J. (1982). Reductive metabolism of carbon tetrachloride by human cytochromes P-450 reconstituted in phospholipid vesicles: mass spec- tral identification of trichloromethyl radical bound to dioleoyl phos- phatidylcholine. Proc. Natl. Acad. Sci. U.S.A. 79, 2678-2682.
39. Wallnofer, H., and Hanusch, M. (1973). Essential phospholipids for therapy in liver diseases. Med. Monatsschr. 27, 131-136.
40. Whiting, P. H., Bowley, M., Sturton, R. G., Pritchard, P. H., Brindley, D. N., and Hawthorne, J. N. (1977). The effect of chronic diabetes, induced by streptozotocin, on the activities of some enzymes of glycerolipid syn- thesis in rat liver. Biochem. J. 168, 147-153.
41. Yan, J. J., Jung, J. S., Lee, J. E., Lee, J., Huh, S. O., Kim, H. S., Jung, K. C., Cho, J. Y., Nam, J. S., Suh, H. W., Kim, Y. H., and Song, D. K. (2004). Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat. Med. 10, 161-167.
42. Zhang, F., Pan, T., Nielsen, L. D., and Mason, R. J. (2004). Lipogenesis in fetal rat lung: importance of C/EBPalpha, SREBP-1c, and stearoyl-CoA desaturase. Am. J. Respir. Cell Mol. Biol. 30, 174-183.